Cerebral small vessel disease: targeting oxidative stressas a novel therapeutic strategy?
Cerebral small vessel disease (SVD) is a major contributor to stroke, and a leading cause of cognitive impairment and dementia. Despite the devastating effects of cerebral SVD, the pathogenesis of cerebral SVD is still not completely understood. Moreover, there are no specific pharmacological strate...
Main Authors: | Alyson Anne Miller, T. Michael eDe Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00061/full |
Similar Items
-
NADPH Oxidase Activity in Cerebral Arterioles Is a Key Mediator of Cerebral Small Vessel Disease—Implications for Prevention
by: Mark F. McCarty
Published: (2015-04-01) -
H<sub>2</sub>O<sub>2</sub> Metabolism in Normal Thyroid Cells and in Thyroid Tumorigenesis: Focus on NADPH Oxidases
by: Ildiko Szanto, et al.
Published: (2019-05-01) -
NOX1-dependent redox signaling potentiates colonic stem cell proliferation to adapt to the intestinal microbiota by linking EGFR and TLR activation
by: Sjoerd van der Post, et al.
Published: (2021-04-01) -
Implication of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Its Inhibitors in Alzheimer’s Disease Murine Models
by: Leticia Guadalupe Fragoso-Morales, et al.
Published: (2021-02-01) -
NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses
by: Fan Jiang, et al.
Published: (2014-01-01)